These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7331657)

  • 1. Granulocyte chemotaxis in Crohn's disease.
    Belsheim J; Gnarpe H; Persson S
    Acta Chir Scand; 1981; 147(3):197-200. PubMed ID: 7331657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of nitroimidazole derivatives on leukocyte migration.
    Gnarpe H; Belsheim J; Persson S
    Scand J Infect Dis Suppl; 1981; 26():68-71. PubMed ID: 6941458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma lysozyme levels and decay of neutrophilic granulocytes in patients with Crohn's disease.
    van de Merwe JP; Lindemans J; Mol GJ
    Hepatogastroenterology; 1980 Apr; 27(2):130-4. PubMed ID: 7216126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte chemotaxis in ulcerative colitis.
    Belsheim J; Gnarpe H; Swahn A
    Acta Pathol Microbiol Immunol Scand C; 1984 Feb; 92(1):75-9. PubMed ID: 6711311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total parenteral nutrition modifies the acute phase response to Crohn's disease.
    Carlson GL; Gray P; Barber D; Shaffer JL; Mughal M; Irving MH
    J R Coll Surg Edinb; 1994 Dec; 39(6):360-4. PubMed ID: 7532715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open-labelled study of granulocyte colony-stimulating factor in the treatment of active Crohn's disease.
    Korzenik JR; Dieckgraefe BK
    Aliment Pharmacol Ther; 2005 Feb; 21(4):391-400. PubMed ID: 15709989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basic fibroblast growth factor as a response parameter to infliximab in fistulizing Crohn's disease.
    Gao Q; Hogezand RA; Lamers CB; Verspaget HW
    Aliment Pharmacol Ther; 2004 Sep; 20(5):585-92. PubMed ID: 15339330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.
    Niederau C; Backmerhoff F; Schumacher B; Niederau C
    Hepatogastroenterology; 1997; 44(13):90-107. PubMed ID: 9058126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Atopic dermatitis. IV. Granulocyte chemotaxis].
    Silny W
    Przegl Dermatol; 1983; 70(5-6):475-80. PubMed ID: 6669717
    [No Abstract]   [Full Text] [Related]  

  • 10. Decreased beta-endorphin content in peripheral blood mononuclear leukocytes from patients with Crohn's disease.
    Wiedermann CJ; Sacerdote P; Propst A; Propst T; Judmaier G; Kathrein H; Vogel W; Panerai AE
    Brain Behav Immun; 1994 Sep; 8(3):261-9. PubMed ID: 7865897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between levels of C-reactive protein and clinical activity in Crohn's disease.
    Karoui S; Ouerdiane S; Serghini M; Jomni T; Kallel L; Fekih M; Boubaker J; Filali A
    Dig Liver Dis; 2007 Nov; 39(11):1006-10. PubMed ID: 17889628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukotriene B4 receptor levels and intracellular calcium signalling in polymorphonuclear leukocytes from patients with Crohn's disease.
    Bouchelouche PN; Berild D; Nielsen OH; Elmgreen J; Poulsen HS
    Eur J Gastroenterol Hepatol; 1995 Apr; 7(4):349-56. PubMed ID: 7600141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The leukocyte count predicts the efficacy of treatment with azathioprine in inflammatory bowel disease.
    Glas J; Török HP; Daczo J; Tonenchi L; Folwaczny M; Folwaczny C
    Eur J Med Res; 2005 Dec; 10(12):535-8. PubMed ID: 16356870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postsurgical granulocyte dysfunction: studies in healthy kidney donors.
    Bowers TK; O'Flaherty J; Simmons RL; Jacob HS
    J Lab Clin Med; 1977 Oct; 90(4):720-7. PubMed ID: 903700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating growth-regulator oncogene alpha contributes to neutrophil priming and interleukin-8-directed mucosal recruitment into chronic lesions of patients with Crohn's disease.
    Brandt E; Müller-Alouf H; Desreumaux P; Woerly G; Colombel JF; Capron M
    Eur Cytokine Netw; 1998 Dec; 9(4):647-53. PubMed ID: 9889409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma levels of endothelin-1 in patients with Crohn's disease and ulcerative colitis.
    Letizia C; Boirivant M; De Toma G; Cerci S; Subioli S; Scuro L; Ferrari P; Pallone F
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):266-9. PubMed ID: 9759593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune activation and nutritional status in adult Crohn's disease patients.
    Reimund JM; Arondel Y; Escalin G; Finck G; Baumann R; Duclos B
    Dig Liver Dis; 2005 Jun; 37(6):424-31. PubMed ID: 15893281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natalizumab for the treatment of active Crohn's disease: results of the ENCORE Trial.
    Targan SR; Feagan BG; Fedorak RN; Lashner BA; Panaccione R; Present DH; Spehlmann ME; Rutgeerts PJ; Tulassay Z; Volfova M; Wolf DC; Hernandez C; Bornstein J; Sandborn WJ;
    Gastroenterology; 2007 May; 132(5):1672-83. PubMed ID: 17484865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced superoxide anion release of normal neutrophil granulocytes primed with sera of patients with inactive inflammatory bowel disease.
    Griga T; Tromm A; Schwegler U; May B
    Z Gastroenterol; 1995 Jul; 33(6):345-8. PubMed ID: 7668025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective neutrophil chemotaxis corrected by levamisole in Crohn's disease.
    Patrone F; Dallegri F; Sacchetti C
    Acta Hepatogastroenterol (Stuttg); 1978 Aug; 25(4):322-3. PubMed ID: 696210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.